Patient preference and decision-making for initiating metastatic colorectal cancer medical treatment

  title={Patient preference and decision-making for initiating metastatic colorectal cancer medical treatment},
  author={A. Z. Fu and K. Graves and R. Jensen and J. Marshall and Margaret Formoso and A. Potosky},
  journal={Journal of Cancer Research and Clinical Oncology},
  • A. Z. Fu, K. Graves, +3 authors A. Potosky
  • Published 2015
  • Medicine
  • Journal of Cancer Research and Clinical Oncology
  • AbstractPurpose Some medical treatment for metastatic colorectal cancer (CRC) may have marginal survival benefit, but cause toxicities. The purpose of this study is to determine metastatic CRC patients’ tradeoffs in making a decision to undergo new medical treatment.MethodsWe conducted a survey of patients with a diagnosis of advanced CRC who were currently receiving or completed one chemotherapy regimen. First, patients were asked to rate the importance of 15 medical treatment-related adverse… CONTINUE READING
    Influential factors on treatment decision making among patients with colorectal cancer: A scoping review
    • 5
    • Highly Influenced
    Societal preferences for adjuvant melanoma health states: UK and Australia
    • 3


    Publications referenced by this paper.
    Patients' expectations about effects of chemotherapy for advanced cancer.
    • 519
    • PDF
    Congestive heart failure risk in patients with breast cancer treated with bevacizumab.
    • 234
    • PDF
    Chemotherapy Use, Performance Status, and Quality of Life at the End of Life.
    • 275
    • PDF
    A Decision Analysis for Treatment of Clinically Localized Prostate Cancer
    • 79
    Risk/benefit profile of bevacizumab in metastatic colon cancer: a systematic review and meta-analysis.
    • 41
    Sharing decisions in cancer care.
    • 473